Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

CMPX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 25, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Compass Therapeutics Inc. (CMPX)

Based on 20 analysts giving stock ratings to Compass Therapeutics Inc. in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
40
Buy
50
Hold
10
Sell
0
Strong Sell
0
Compass Therapeutics Inc.

Compass Therapeutics Inc.. Stock Analysis CMPX

United States Health Care Small Cap Report:
The company is headquartered in Boston, Massachusetts and currently employs 39 full-time employees. The company went IPO on 2020-11-13.
Read More

Compass Therapeutics Inc. (CMPX) Chart

Key Statistics of Compass Therapeutics Inc. (CMPX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.04$2.11

Today's Open

$2.04

Volume

3.11M

P/E Ratio (TTM)

-

52 Week Range

$1.61$6.88

Market Cap

347.57M

Avg. Volume

4.03M

Dividend Yield

-

Financial Metrics & Statements of Compass Therapeutics Inc. (CMPX)

FAQ's for Compass Therapeutics Inc. (CMPX)

  • According to Musaffa’s Shariah screening methodology, Compass Therapeutics Inc. (CMPX) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Compass Therapeutics Inc. using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Compass Therapeutics Inc. if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Compass Therapeutics Inc. by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Compass Therapeutics Inc. may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Compass Therapeutics Inc. on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.